Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

Show other versions (2)

Background: Evaluating the long term benefit of therapy in multiple sclerosis (MS) is challenging. Although randomised controlled trials (RCTs) demonstrate therapeutic benefits on short term outcomes, the relationship between these outcomes and late disability is not established. Methods: In a patie...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Goodin, D, Traboulsee, A, Knappertz, V, Reder, A, Li, D, Langdon, D, Wolf, C, Beckmann, K, Konieczny, A, Ebers, G
פורמט:	Journal article
יצא לאור:	2012

פריטים דומים

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
מאת: Goodin, D, et al.
יצא לאור: (2012)

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
מאת: Goodin, D, et al.
יצא לאור: (2012)

Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
מאת: Goodin, D, et al.
יצא לאור: (2012)

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study
מאת: Goodin, D, et al.
יצא לאור: (2012)

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
מאת: Ebers, G, et al.
יצא לאור: (2009)

Mortality in patients with multiple sclerosis.
מאת: Scalfari, A, et al.
יצא לאור: (2013)

Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.
מאת: Ebers, G, et al.
יצא לאור: (2010)

CAUSE OF DEATH IN MULTIPLE SCLEROSIS PATIENTS FROM THE 21-YEAR LONG-TERM FOLLOW-UP STUDY
מאת: Ebers, G, et al.
יצא לאור: (2011)

The final results of the interferon beta-1b 16-year long-term follow-up study
מאת: Ebers, G, et al.
יצא לאור: (2006)

The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
מאת: Reder, A, et al.
יצא לאור: (2008)

Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
מאת: Reder, A, et al.
יצא לאור: (2010)

EDSS and MRI burden of disease predict cognitive status at 16 years: data from the long term follow-up study
מאת: Langdon, D, et al.
יצא לאור: (2007)

Establishing long-term efficacy in chronic disease: use of recursive partitioning and propensity score adjustment to estimate outcome in MS.
מאת: Douglas S Goodin, et al.
יצא לאור: (2011-01-01)

16-year long-term follow-up of interferon beta-1b treatment in patients with multiple sclerosis
מאת: Ebers, G, et al.
יצא לאור: (2005)

Long-term follow up of interferon-beta-1b pivotal trial RRMS patients: design issues of a 16-year follow-up study
מאת: Ebers, G, et al.
יצא לאור: (2004)

Causes of death among commercially insured multiple sclerosis patients in the United States.
מאת: Douglas S Goodin, et al.
יצא לאור: (2014-01-01)

Treatment of multiple sclerosis with interferon beta-1b - Reply
מאת: Sibley, W, et al.
יצא לאור: (1997)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
מאת: Sibley, W, et al.
יצא לאור: (1994)

Interferons in relapsing remitting multiple sclerosis.
מאת: Goodin, D
יצא לאור: (2003)

Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972))
מאת: Goodin, D, et al.
יצא לאור: (2013)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
מאת: Petkau, A, et al.
יצא לאור: (2004)

A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
מאת: Colin J. Ross, et al.
יצא לאור: (2017-05-01)

Systemic interferon alfa in multiple sclerosis.
מאת: Weinshenker, BG, et al.
יצא לאור: (1989)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
מאת: Ebers, G, et al.
יצא לאור: (1997)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
מאת: Filippini, G, et al.
יצא לאור: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
מאת: Filippini, G, et al.
יצא לאור: (2003)

Age and disability accumulation in multiple sclerosis.
מאת: Scalfari, A, et al.
יצא לאור: (2011)

Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis
מאת: Paul I. Creeke, et al.
יצא לאור: (2013-01-01)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
מאת: Ebers, G, et al.
יצא לאור: (1998)

Interferons in relapsing remitting multiple sclerosis: a systematic review.
מאת: Filippini, G, et al.
יצא לאור: (2003)

Interferon-β corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection
מאת: Xuan Feng, et al.
יצא לאור: (2019-11-01)

The evolution of interferon therapy in multiple sclerosis
מאת: O. V. Boyko, et al.
יצא לאור: (2023-08-01)

Drug induced liver injury secondary to interferon-beta (IFN-β) in multiple sclerosis
מאת: V. Byrnes, et al.
יצא לאור: (2006-01-01)

Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy
מאת: A. D. Kukushkina, et al.
יצא לאור: (2024-08-01)

Association of smoking with risk of multiple sclerosis: a population-based study.
מאת: Ramagopalan, S, et al.
יצא לאור: (2013)

Association of smoking with risk of multiple sclerosis: A population-based study
מאת: Ramagopalan, S, et al.
יצא לאור: (2013)

Adherence to interferon β treatment in Kosovan multiple sclerosis registry
מאת: Blerim Myftiu, et al.
יצא לאור: (2024-01-01)

EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN
מאת: L. M. Kuzenkova, et al.
יצא לאור: (2013-09-01)

Interferon beta treatment of multiple sclerosis.
מאת: Markovitz, D
יצא לאור: (1994)

CLINICALLY ISOLATED SYNDROME IN CHILDREN AND ADOLESCENTS — RISK FACTORS FOR MULTIPLE SCLEROSIS AND PROSPECTS OF USING INTRAMUSCULAR INTERFERON β-1A
מאת: O.V. Bykova, et al.
יצא לאור: (2010-05-01)